Invitrogen and Illumina Announce Strategic Alliance
Synthesis, Distribution and Marketing Strengths For Global Life Sciences Customers
21-Dec-2004 -
Invitrogen Corporation (NASDAQ: IVGN) and Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration to leverage their respective strengths in nucleic acid synthesis and distribution to deliver oligonucleotides of unequaled value to the life sciences market worldwide. The ...
acids
Invitrogen
Life Sciences
+2